Skip to content

expression in cancer cells and correlates with patient survival in breast, ovarian and gastric cancer

· 0 citations · 22 references

TL;DR

The present study proposes the possibility of PRMT8 as a cancer biomarker, based on the high level of PRMT8 expression in various types of cancer, particularly in tissues that would not normally be expected to express PRMT8, and on the correlation of PRMT8 and patient lifespan in several cancer types.

View source

Similar papers

Sep 2026

Identification of STK35L1 as a potential prognostic biomarker in breast carcinoma, and its expression exhibits high correlation with EGFR activity

An association of STK35L1 and EGFR in BC is reported, highlighting STK35L1 as a potential prognostic biomarker and therapeutic target and suggesting that EGFR-STAT3 signaling may regulate STK35L1 and EGFR expression.

Saloni Bage, Arpana Yadav, Kritika Gaur et al. · 0 citations
Aug 2026

Elevated Expression of LINC02257 and LINC00659 in Breast Cancer is Associated with Poor Survival and Immune Cell Infiltration

This study found that LINC02257 and LINC00659 are upregulated in BC and are associated with malignancy-related genes and patient survival, suggesting their potential as therapeutic targets and prognostic biomarkers.

Fatemeh Badzohre, Azin Azadfekr, Farnoosh Akbari et al. · 0 citations
Open access Sep 2026

LIMCH1 is Downregulated and Associated With Poor Prognosis, and Suppresses Tumor Cell Proliferation and Invasion in Ovarian Cancer

Background: LIM and calponin homology domain-containing protein 1 (LIMCH1) regulates myosin stress fiber assembly and cell motility and is involved in carcinogenesis. However, its role in ovarian cancer remains poorly characterized. In this study, LIMCH1 was identified as a candidate tumor suppressor gene through analy...

Peng-Feng Zhu, Xiang Fan, Yi-Fei Wang et al. · 0 citations
Open access Sep 2026

Pan-cancer prognostic value of TGFBR1: Bioinformatics and experimental validation with a focus on gastric cancer

TGF-β receptor 1 (TGFBR1) is a key component of TGF-β signaling and has been implicated in tumor progression. However, its expression patterns, prognostic relevance and associated molecular contexts vary among malignancies and remain incompletely characterized within a consistent pan-cancer framework. In the present st...

Xia Zhao, Lu-Fan Shen, Zhi-Yuan Gong et al. · 0 citations
Open access Oct 2026

Pan-cancer and experimental analyses reveal TTC39B as a suppressor of cell proliferation in clear cell renal cell carcinoma

Tetratricopeptide repeat domain protein 39B (TTC39B) is a lipid metabolism–related gene recently implicated in cholesterol regulation. However, its clinical and biological relevance in human cancers remains undefined. Based on multi-omics data from the Cancer Genome Atlas (TCGA) pan-cancer dataset represen...

Hui-Juan Yi, Yan Wang, Chen-Hao Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.